Aquestive Therapeutics Income Statement (2017-2025) | AQST

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 11.14M17.00M12.19M23.41M13.93M13.27M16.82M12.64M11.13M1.00M16.42M8.77M0.50M4.00M8.00M8.00M2.00M13.29M11.08M12.27M8.00M11.46M10.68M11.13M13.24M13.00M13.21M12.05M20.10M13.54M-44.69M8.72M10.00M12.81M
Gross Profit 6.00M12.12M6.58M17.77M8.96M7.67M12.04M9.14M5.71M-3.64M9.63M5.11M-3.04M1.02M5.21M5.24M-2.47M8.89M7.71M8.06M2.76M6.84M5.38M6.40M6.62M8.20M7.72M7.66M15.57M9.11M-49.21M5.07M5.44M8.30M
Operating items
Research & Development 5.34M5.68M6.27M4.90M7.99M4.53M5.68M4.30M8.15M5.06M3.06M4.35M3.85M7.26M4.42M3.66M4.26M4.73M4.40M4.77M5.20M3.23M4.28M3.55M3.47M3.20M2.89M5.93M4.16M5.27M4.92M5.36M4.11M4.53M
Selling, General & Administrative 6.13M6.16M7.57M7.57M33.67M12.35M18.71M17.91M16.25M13.71M16.47M14.61M13.89M11.80M15.58M13.23M13.13M12.13M14.98M13.02M15.59M12.46M11.81M7.46M7.36M7.38M9.55M10.69M11.36M12.13M16.01M19.07M12.71M15.25M
Other Operating Expenses 3.73M4.88M5.61M5.64M4.95M5.59M4.78M3.51M5.42M4.64M6.79M3.66M3.54M2.98M2.79M2.76M4.47M4.40M3.37M4.21M5.24M4.62M5.30M4.74M6.62M4.80M4.68M4.39M4.53M4.44M4.52M3.65M4.56M4.51M
Operating Expenses 15.20M16.73M19.45M18.11M46.61M22.47M29.17M25.72M29.82M23.42M26.32M22.63M21.28M22.04M22.80M19.65M21.86M21.25M22.75M22.01M26.03M20.32M21.39M15.74M17.45M15.38M17.12M21.01M20.04M21.83M25.45M28.09M21.37M24.29M
Operating Income 0.78M10.42M-7.26M5.30M-32.71M-9.21M-12.35M-13.07M-18.69M-11.00M-9.90M-13.86M0.40M-13.78M-15.65M-8.53M-6.52M-7.97M-11.67M-9.74M-12.76M-8.85M-10.71M-4.61M-4.21M-2.38M-3.91M-8.96M0.06M-8.29M-13.58M-19.36M-11.37M-11.48M
EBIT 0.78M10.42M-7.26M5.30M-32.71M-9.21M-12.35M-13.07M-18.69M-11.00M-9.90M-13.86M0.40M-13.78M-15.65M-8.53M-6.52M-7.97M-11.67M-9.74M-12.76M-8.85M-10.71M-4.61M-4.21M-2.38M-3.91M-8.96M0.06M-8.29M-13.58M-19.36M-11.37M-11.48M
Non-operating items
Interest & Investment Income 0.02M0.22M0.31M0.27M0.15M0.14M0.07M0.10M0.02M0.01M0.00M-0.05M0.37M-0.03M0.14M-0.00M0.03M0.01M0.07M14.51M0.13M1.51M0.17M0.33M1.40M0.98M0.73M0.71M2.10M0.31M
Other Non Operating Income -4.90M-0.35M-1.03M
Net income details
EBT -1.46M8.45M-10.04M4.10M-36.49M-15.04M-13.94M-14.73M-20.47M-18.41M-12.64M-16.53M-2.33M-16.55M-20.37M-14.67M-12.37M-14.55M-28.95M-13.22M-16.30M-12.54M-12.35M8.07M-5.51M-2.17M-8.01M-12.83M-2.75M-11.51M-17.07M-22.93M-13.55M-15.45M
Tax Provisions 0.28M-0.14M0.10M-0.01M
Profit After Tax -5.90M8.45M-10.04M4.10M-36.49M-15.04M-13.94M-14.73M-20.47M-18.41M-12.64M-16.53M-2.33M-16.55M-20.37M-14.67M-12.37M-14.55M-28.95M-13.22M-16.30M-12.54M-12.35M8.07M-5.79M-2.04M-8.11M-12.83M-2.75M-11.51M-17.05M-22.93M-13.55M-15.45M
Income from Continuing Operations -1.46M8.45M-10.04M4.10M-36.49M-15.04M-13.94M-14.73M-20.47M-18.41M-12.64M-16.53M-2.33M-16.55M-20.37M-14.67M-12.37M-14.55M-28.95M-13.22M-16.30M-12.54M-12.35M8.07M-5.79M-2.04M-8.11M-12.83M-2.75M-11.51M-17.05M-22.93M-13.55M-15.45M
Consolidated Net Income -1.46M8.45M-10.04M4.10M-36.49M-15.04M-13.94M-14.73M-20.47M-18.41M-12.64M-16.53M-2.33M-16.55M-20.37M-14.67M-12.37M-14.55M-28.95M-13.22M-16.30M-12.54M-12.35M8.07M-5.79M-2.04M-8.11M-12.83M-2.75M-11.51M-17.05M-22.93M-13.55M-15.45M
Income towards Parent Company -1.46M8.45M-10.04M4.10M-36.49M-15.04M-13.94M-14.73M-20.47M-18.41M-12.64M-16.53M-2.33M-16.55M-20.37M-14.67M-12.37M-14.55M-28.95M-13.22M-16.30M-12.54M-12.35M8.07M-5.79M-2.04M-8.11M-12.83M-2.75M-11.51M-17.05M-22.93M-13.55M-15.45M
Preferred Dividend Payments 0.61M0.63M0.63M
Net Income towards Common Stockholders -2.07M7.83M-10.67M4.10M4.10M-15.04M-13.94M-14.73M-20.47M-18.41M-12.64M-16.53M-2.33M-16.55M-20.37M-14.67M-12.37M-14.55M-28.95M-13.22M-16.30M-12.54M-12.35M8.07M-5.79M-2.04M-8.11M-12.83M-2.75M-11.51M-17.05M-22.93M-13.55M-15.45M
Additional items
EPS (Basic) -0.440.27-1.90-0.64-0.56-0.59-0.82-0.74-0.48-0.49-0.07-0.49-0.60-0.41-0.33-0.37-0.73-0.32-0.36-0.23-0.220.15-0.10-0.03-0.13-0.17-0.03-0.13-0.19-0.24-0.14-0.14
EPS (Weighted Average and Diluted) -0.49-0.07-0.49-0.61-0.41-0.33-0.37-0.73-0.32-0.36-0.23-0.220.11-0.10-0.03-0.13-0.17-0.03-0.13-0.19-0.24-0.14-0.14
Shares Outstanding (Weighted Average) 24.00M24.00M24.00M24.94M24.94M24.98M24.98M25.03M25.04M33.58M33.58M33.62M33.62M36.21M36.59M38.89M40.16M41.47M41.91M53.35M54.16M55.87M55.92M61.73M66.77M73.30M91.04M91.06M91.18M98.87M99.33M99.72M
Shares Outstanding (Diluted Average) 33.57M33.62M33.65M35.56M37.07M39.22M38.08M41.47M45.46M53.42M48.73M73.79M58.94M64.68M61.26M73.61M90.91M91.08M86.73M95.50M99.33M110.58M
EBITDA -2.07M7.83M-10.67M4.10M-36.49M-15.04M-13.94M-14.73M-20.47M-18.41M-12.64M-16.53M-2.33M-16.55M-20.37M-14.67M-12.37M-14.55M-28.95M-13.22M-16.30M-12.54M-12.35M8.07M-5.79M-2.04M-8.11M-12.83M-2.75M-11.51M-17.05M-22.93M-13.55M-15.45M
Interest Expenses 1.82M1.97M1.97M1.93M1.93M1.93M1.90M1.93M1.94M2.65M2.80M2.77M2.75M2.78M2.77M2.76M2.76M2.79M1.74M1.62M1.64M1.65M1.65M1.44M1.37M1.26M2.27M2.78M2.78M2.78M2.78M2.78M2.78M2.78M
Shares Outstanding 0.01M15.08M20.00M24.94M24.96M24.98M25.02M25.04M33.56M33.58M33.62M33.62M34.57M36.24M38.57M40.08M41.23M41.62M53.34M53.85M54.83M55.92M61.62M66.74M68.53M90.48M91.06M91.18M91.41M99.32M99.35M121.66M
Tax Rate 6.440.08